ARD Podcast

ARD Podcast

Download on the App Store

ARD Podcast episodes

  • Prediction of radiographic progression using synovitis characteristics

    Dr. Felice Rivellese from the Center of Experimental Medicine and Rheumatology at the Queen Mary University in London discusses the results of his presentation at the ACR 2019 with Dr. Caroline Ospelt. In a subanalysis of the pathobiology of the Early Arthitis Cohort (PEAC), Rivellese at al could show that B cell-rich synovitis is associated with disease severity and radiographic progression, in particular, if B cell infiltrates persist after cDMARD treatment.

    11 min
  • Highlights from ACR: guselkumab, ixekizumab and secukinumab in SpA

    Atul Deodhar, from the Oregon Health & Science University, provides an overview of recent clinical trial results in the area of seronegative Spondylarthritis. He presented the 24-week data of Guselkumab in active psoriatic arthritis patients in the DISCOVER-1 study and compared the phase 3 trials in non-radiographic SpA patients on Ixekizumab (COAST-X) and Secukinumab (PREVENT) with up to 52 week data available.

    15 min
  • TULIP 2: Efficacy and Safety of Anifrolumab in Patients
    TULIP 2: Efficacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial.

    In this second phase 3 trial, the primary endpoint, BICLA, was achieved, and anifrolumab was superior to placebo for multiple secondary efficacy endpoints, including SRI(4), skin disease, and oral corticosteroid tapering.

    4 min
  • TULIP 1 - highlights from the ACR meeting
    TULIP 1: A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus

    In this first phase 3 trial, the primary endpoint, SRI(4), was not achieved, but numeric improvements achieving thresholds associated with clinical benefit were observed for BICLA, oral corticosteroid tapering and other organ-specific endpoints.

    5 min
  • Capture Hi-C reveals novel drug targets in rheumatic diseases
    The paper discussed in this podcast provides an approach, using Capture Hi-C data, to link genetic associations to potential causal genes and assess the potential of drug repurposing in three rheumatic diseases. This has the potential to identify genes which are functionally relevant and the target of existing therapies, which could provide new ways to treat patients, enhancing their quality of life and reducing the economic impact on healthcare providers.

    Read the full paper on the ARD website: https://ard.bmj.com/content/78/8/1127.

    15 min
  • Musculoskeletal diseases on the rise worldwide and affecting developed countries the most
    Musculoskeletal diseases have increased significantly between 2000 and 2015 and are now the second cause of years lived with disability worldwide, a study recently published by ARD concludes. The paper also adds that the burden is higher in Europe.
    “The richest the country, the highest the burden of musculoskeletal diseases”, says the leading author. Professor Laurent Arnaud and Dr Eden Sebbag(Department of Rheumatology - Centre National de Référence des Maladies Systémiques Rares Est Sud-Ouest, Hôpitaux Universitaires de Strasbourg, France) discuss the details of the study with ARD's Social Media Advisor, Dr Paul Studenic.

    Read the full paper: https://ard.bmj.com/content/78/6/844.

    14 min
  • Three tips to get your manuscript published by ARD
    Find out how to increase your chances of a successful submission in this very short podcast with Annals of the Rheumatic Diseases’s Associate Editor Francis Berenbaum. He is interviewed by the Social Media Advisor of the journal, Christophe Richez.
    Read more information for authors on the ARD website: https://ard.bmj.com/pages/authors/.

    Submit your manuscript here: https://mc.manuscriptcentral.com/ard.

    5 min
  • Early inflammatory arthritis outcomes: what changed in the new millennium?
    A study that compares the 10-year outcome (disease activity, disability, mortality) of two cohorts of patients with inflammatory polyarthritis recruited 10 years apart is discussed in this podcast. The results from the UK’s Norfolk Arthritis Register are shared by two of its co-authors from the Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, School of Biological Sciences, Manchester Academic Health Science Centre: James Gwinnutt and Suzanne Verstappen (NIHR Manchester Biomedical Research Centre) in conversation with the social media advisor for ARD Meghna Jani.

    Read the full paper on the Annals of the Rheumatic Diseases website: https://ard.bmj.com/content/77/6/848.

    10 min

About ARD Podcast

From the publisher's feed

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of…

More shows like ARD Podcast

Medicine and Science from The BMJ by The BMJ

Medicine and Science from The BMJ

34 Listeners

BJSM Podcast by BMJ Group

BJSM Podcast

47 Listeners

DTB Podcast by BMJ Group

DTB Podcast

6 Listeners

Gut Podcast by BMJ Group

Gut Podcast

8 Listeners

Sharp Scratch by The BMJ

Sharp Scratch

5 Listeners

ADC Podcast by BMJ Group

ADC Podcast

3 Listeners

Thorax Podcast by BMJ Group

Thorax Podcast

1 Listeners

STI Podcast by BMJ Group

STI Podcast

3 Listeners

JNNP Podcast by BMJ Group

JNNP Podcast

9 Listeners

Heart Podcast by BMJ Group

Heart Podcast

40 Listeners

JNIS Podcast by BMJ Group

JNIS Podcast

14 Listeners

EBN Podcast by BMJ Group

EBN Podcast

1 Listeners

Practical Neurology Podcast by BMJ Group

Practical Neurology Podcast

51 Listeners

FG Podcast by BMJ Group

FG Podcast

0 Listeners

Medical Humanities Podcast by BMJ Group

Medical Humanities Podcast

6 Listeners

Lupus Science and Medicine Podcast by BMJ Group

Lupus Science and Medicine Podcast

15 Listeners

RMD Open Podcast by BMJ Group

RMD Open Podcast

3 Listeners

BMJ Best Practice Podcast by BMJ Group

BMJ Best Practice Podcast

27 Listeners

IJGC Podcast by BMJ Group

IJGC Podcast

24 Listeners

BMJ Future Health Podcast by BMJ Publishing Group

BMJ Future Health Podcast

0 Listeners